Skip to main content
. 2022 Feb 1;132(3):e153173. doi: 10.1172/JCI153173

Figure 2. Efficacy of CERC-002 in COVID-19 patients.

Figure 2

Percentage of patients alive and free of respiratory failure through 28 days after treatment is presented. Analysis was performed for overall (n = 62) patients, and separately for subgroups of patients under the age of 60 (n = 34) and age 60 or above (n = 28). One-sided P values were calculated using the Wald χ2 test.